Thursday, July 25, 2024 3:07:40 PM
Nemesis18,
So tell me, how does what you are doing because of what you went through help older rGBM patients that did not have a second resection event sooner than those who did have a second resection before receiving DCVax-L?; ). Hint: It doesn’t; ). Nothing you are doing here is helpful to those who can benefit from this treatment. In fact your logic supports the idea that what was learned about how this treatment is beneficial to some patient groups on its own, with additional insights added from other trials that a wider patient group can receive benefit from actuators and combos, should all be ignored so that those patient groups are left to suffer instead of having a chance at a longer term reprieve or even a cure. If you would have investigated this all more thoroughly instead of let your own pain get in the way you would have seen the error of your way. If allowable, I suggest you find a way to communicate with someone from the group of undeniable beneficiaries willing to discuss their journey with you, perhaps on a patient forum, or family of same to help you with this. Best wishes.
So tell me, how does what you are doing because of what you went through help older rGBM patients that did not have a second resection event sooner than those who did have a second resection before receiving DCVax-L?; ). Hint: It doesn’t; ). Nothing you are doing here is helpful to those who can benefit from this treatment. In fact your logic supports the idea that what was learned about how this treatment is beneficial to some patient groups on its own, with additional insights added from other trials that a wider patient group can receive benefit from actuators and combos, should all be ignored so that those patient groups are left to suffer instead of having a chance at a longer term reprieve or even a cure. If you would have investigated this all more thoroughly instead of let your own pain get in the way you would have seen the error of your way. If allowable, I suggest you find a way to communicate with someone from the group of undeniable beneficiaries willing to discuss their journey with you, perhaps on a patient forum, or family of same to help you with this. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
